Global pharmaceutical operations and technology company Biogen partnered with Chinese commercial-stage biopharmaceutical firm InnoCare Pharma to develop a treatment for multiple sclerosis.
https://www.pharmalive.com/wp-content/uploads/2021/04/FDA-Panel-Takes-Another-Swing-at-Biogens-Alzheimers-Candidate-BioSpace-4-1-21.jpeg350625Andrew Humphreyshttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngAndrew Humphreys2021-07-13 11:32:442021-07-13 15:57:03Biogen Scoops Up Exclusive Rights to Chinese Molecule for MS